Tiratricol
Top View
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- Official Title: a Phase 2A, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Evaluating the Efficacy, Safety, Toler
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Cancer Cachexia Appetite Stimulants (Orexigenic Medications)
- HA Drug Formulary External List V12 2 161008 (Dated 161006).Xlsx
- Known Bioactive Library: Microsource Discovery 1
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Hypothyroidism: Overview and Treatment Options
- Téatrois® (Tiratricol, Triac) Repositioned As an Orphan Drug Under the Name “Emcitate” in 2020
- Perioperative Medication Guidelines – 2019
- Tiratricol (TRIAC) Than Are T4 and T3' the Liver Appears to Be the Major Site of Degradation of Tiratricol
- Induces Embryonic Ζ-Globin Expression Via Thyroid Hormone Receptor Α
- A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
- Download Product Insert (PDF)
- Customs Tariff - Schedule Xxi - 1
- Figure S1. Rhod 2 Staining of Intracellular Calcium Depletion
- (12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al